Access cutting-edge fatty liver disease treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access fatty liver disease specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fatty liver disease treatment provided free
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), a major global public health concern, is commonly associated with obesity, diabetes, and dyslipidemia. MASLD is currently the most common cause of chronic liver disease affecting about 80% of people with obesity, ranging from simple fat deposits in the liver to Metabolic Dysfunction-Associated Steatohepatitis (MASH), cellular injury, advanced fibrosis, cirrhosis, or hepa
Sponsor: Ali Aminian
Check if you qualify for this fatty liver disease clinical trial in Rochester, MN
If you're searching for fatty liver disease treatment options in Rochester, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fatty liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.